Shopping Cart 0
Cart Subtotal
AED 0

Pet Healthcare in North America

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
AED 1285

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Site License
AED 2569

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
AED 3854

Details

Pet Healthcare in North America

Summary

Pet Healthcare in North America industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2013-17, and forecast to 2022). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Essential resource for top-line data and analysis covering the North America pet healthcare market. Includes market size and segmentation data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

Key Highlights

- The pet healthcare market consists of retail sale of pet supplements, worming treatments, external parasite treatments, grooming products and other pet healthcare. The market is valued according to retail selling price (RSP) and includes any applicable taxes. All currency conversions used in the creation of this report have been calculated using constant annual average 2017 exchange rates.

- The North American pet healthcare market had total revenues of USD 11,050.4m in 2017, representing a compound annual growth rate (CAGR) of 1.5% between 2013 and 2017.

- Market consumption volume increased with a CAGR of 1.1% between 2013 and 2017, to reach a total of 1,237.0 million units in 2017.

- The US pet healthcare market accounted for 93.6% of the overall North American market in 2017.

Scope

- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the pet healthcare market in North America

- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pet healthcare market in North America

- Leading company profiles reveal details of key pet healthcare market players' global operations and financial performance

- Add weight to presentations and pitches by understanding the future growth prospects of the North America pet healthcare market with five year forecasts by both value and volume

Reasons to buy

- What was the size of the North America pet healthcare market by value in 2017?

- What will be the size of the North America pet healthcare market in 2022?

- What factors are affecting the strength of competition in the North America pet healthcare market?

- How has the market performed over the last five years?

- Who are the top competitiors in North America's pet healthcare market?

READ MORE

Table Of Content

Scope

Table of Contents

Executive Summary 2

Market value 2

Market value forecast 2

Market volume 2

Market volume forecast 2

Category segmentation 2

Geography segmentation 2

Market share 2

Market rivalry 2

Market Overview 7

Market definition 7

Market analysis 7

Market Data 8

Market value 8

Market volume 9

Market Segmentation 10

Category segmentation 10

Geography segmentation 11

Market share 12

Market distribution 13

Market Outlook 14

Market value forecast 14

Market volume forecast 15

Five Forces Analysis 16

Summary 16

Buyer power 17

Supplier power 18

New entrants 19

Threat of substitutes 20

Degree of rivalry 21

Leading Companies 22

Bayer AG 22

Eli Lilly and Company 26

Neogen Corp 30

Zoetis Inc. 33

Methodology 35

Industry associations 36

Related MarketLine research 36

Appendix 37

About MarketLine 37


List Of Figure

List of Figures

Figure 1: North America pet healthcare market value: USD million, 2013-17

Figure 2: North America pet healthcare market volume: million units, 2013-17

Figure 3: North America pet healthcare market category segmentation: % share, by value, 2017

Figure 4: North America pet healthcare market geography segmentation: % share, by value, 2017

Figure 5: North America pet healthcare market share: % share, by value, 2017

Figure 6: North America pet healthcare market distribution: % share, by value, 2017

Figure 7: North America pet healthcare market value forecast: USD million, 2017-22

Figure 8: North America pet healthcare market volume forecast: million units, 2017-22

Figure 9: Forces driving competition in the pet healthcare market in North America, 2017

Figure 10: Drivers of buyer power in the pet healthcare market in North America, 2017

Figure 11: Drivers of supplier power in the pet healthcare market in North America, 2017

Figure 12: Factors influencing the likelihood of new entrants in the pet healthcare market in North America, 2017

Figure 13: Factors influencing the threat of substitutes in the pet healthcare market in North America, 2017

Figure 14: Drivers of degree of rivalry in the pet healthcare market in North America, 2017

Figure 15: Bayer AG: revenues & profitability

Figure 16: Bayer AG: assets & liabilities

Figure 17: Eli Lilly and Company: revenues & profitability

Figure 18: Eli Lilly and Company: assets & liabilities

Figure 19: Neogen Corp: revenues & profitability

Figure 20: Neogen Corp: assets & liabilities

Figure 21: Zoetis Inc.: revenues & profitability


List Of Table

List of Tables

Table 1: North America pet healthcare market value: USD million, 2013-17

Table 2: North America pet healthcare market volume: million units, 2013-17

Table 3: North America pet healthcare market category segmentation: USD million, 2017

Table 4: North America pet healthcare market geography segmentation: USD million, 2017

Table 5: North America pet healthcare market share: % share, by value, 2017

Table 6: North America pet healthcare market distribution: % share, by value, 2017

Table 7: North America pet healthcare market value forecast: USD million, 2017-22

Table 8: North America pet healthcare market volume forecast: million units, 2017-22

Table 9: Bayer AG: key facts

Table 10: Bayer AG: key financials (USD )

Table 11: Bayer AG: key financials (EUR)

Table 12: Bayer AG: key financial ratios

Table 13: Eli Lilly and Company: key facts

Table 14: Eli Lilly and Company: key financials (USD )

Table 15: Eli Lilly and Company: key financial ratios

Table 16: Neogen Corp: key facts

Table 17: Neogen Corp: key financials (USD )

Table 18: Neogen Corp: key financial ratios

Table 19: Zoetis Inc.: key facts

Table 20: Zoetis Inc.: key financials (USD )

Table 21: Zoetis Inc.: key financial ratios

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License: 
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:  
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies


Companies

Bayer AG

Eli Lilly and Company

Neogen Corp

Zoetis Inc.

Company Profile

Company Profile Title

Pet Healthcare in North America

Summary

Pet Healthcare in North America industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2013-17, and forecast to 2022). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Essential resource for top-line data and analysis covering the North America pet healthcare market. Includes market size and segmentation data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

Key Highlights

- The pet healthcare market consists of retail sale of pet supplements, worming treatments, external parasite treatments, grooming products and other pet healthcare. The market is valued according to retail selling price (RSP) and includes any applicable taxes. All currency conversions used in the creation of this report have been calculated using constant annual average 2017 exchange rates.

- The North American pet healthcare market had total revenues of USD 11,050.4m in 2017, representing a compound annual growth rate (CAGR) of 1.5% between 2013 and 2017.

- Market consumption volume increased with a CAGR of 1.1% between 2013 and 2017, to reach a total of 1,237.0 million units in 2017.

- The US pet healthcare market accounted for 93.6% of the overall North American market in 2017.

Scope

- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the pet healthcare market in North America

- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pet healthcare market in North America

- Leading company profiles reveal details of key pet healthcare market players' global operations and financial performance

- Add weight to presentations and pitches by understanding the future growth prospects of the North America pet healthcare market with five year forecasts by both value and volume

Reasons to buy

- What was the size of the North America pet healthcare market by value in 2017?

- What will be the size of the North America pet healthcare market in 2022?

- What factors are affecting the strength of competition in the North America pet healthcare market?

- How has the market performed over the last five years?

- Who are the top competitiors in North America's pet healthcare market?

READ MORE

Scope

Table of Contents

Executive Summary 2

Market value 2

Market value forecast 2

Market volume 2

Market volume forecast 2

Category segmentation 2

Geography segmentation 2

Market share 2

Market rivalry 2

Market Overview 7

Market definition 7

Market analysis 7

Market Data 8

Market value 8

Market volume 9

Market Segmentation 10

Category segmentation 10

Geography segmentation 11

Market share 12

Market distribution 13

Market Outlook 14

Market value forecast 14

Market volume forecast 15

Five Forces Analysis 16

Summary 16

Buyer power 17

Supplier power 18

New entrants 19

Threat of substitutes 20

Degree of rivalry 21

Leading Companies 22

Bayer AG 22

Eli Lilly and Company 26

Neogen Corp 30

Zoetis Inc. 33

Methodology 35

Industry associations 36

Related MarketLine research 36

Appendix 37

About MarketLine 37


List Of Figure

List of Figures

Figure 1: North America pet healthcare market value: USD million, 2013-17

Figure 2: North America pet healthcare market volume: million units, 2013-17

Figure 3: North America pet healthcare market category segmentation: % share, by value, 2017

Figure 4: North America pet healthcare market geography segmentation: % share, by value, 2017

Figure 5: North America pet healthcare market share: % share, by value, 2017

Figure 6: North America pet healthcare market distribution: % share, by value, 2017

Figure 7: North America pet healthcare market value forecast: USD million, 2017-22

Figure 8: North America pet healthcare market volume forecast: million units, 2017-22

Figure 9: Forces driving competition in the pet healthcare market in North America, 2017

Figure 10: Drivers of buyer power in the pet healthcare market in North America, 2017

Figure 11: Drivers of supplier power in the pet healthcare market in North America, 2017

Figure 12: Factors influencing the likelihood of new entrants in the pet healthcare market in North America, 2017

Figure 13: Factors influencing the threat of substitutes in the pet healthcare market in North America, 2017

Figure 14: Drivers of degree of rivalry in the pet healthcare market in North America, 2017

Figure 15: Bayer AG: revenues & profitability

Figure 16: Bayer AG: assets & liabilities

Figure 17: Eli Lilly and Company: revenues & profitability

Figure 18: Eli Lilly and Company: assets & liabilities

Figure 19: Neogen Corp: revenues & profitability

Figure 20: Neogen Corp: assets & liabilities

Figure 21: Zoetis Inc.: revenues & profitability


List Of Table

List of Tables

Table 1: North America pet healthcare market value: USD million, 2013-17

Table 2: North America pet healthcare market volume: million units, 2013-17

Table 3: North America pet healthcare market category segmentation: USD million, 2017

Table 4: North America pet healthcare market geography segmentation: USD million, 2017

Table 5: North America pet healthcare market share: % share, by value, 2017

Table 6: North America pet healthcare market distribution: % share, by value, 2017

Table 7: North America pet healthcare market value forecast: USD million, 2017-22

Table 8: North America pet healthcare market volume forecast: million units, 2017-22

Table 9: Bayer AG: key facts

Table 10: Bayer AG: key financials (USD )

Table 11: Bayer AG: key financials (EUR)

Table 12: Bayer AG: key financial ratios

Table 13: Eli Lilly and Company: key facts

Table 14: Eli Lilly and Company: key financials (USD )

Table 15: Eli Lilly and Company: key financial ratios

Table 16: Neogen Corp: key facts

Table 17: Neogen Corp: key financials (USD )

Table 18: Neogen Corp: key financial ratios

Table 19: Zoetis Inc.: key facts

Table 20: Zoetis Inc.: key financials (USD )

Table 21: Zoetis Inc.: key financial ratios

Single User License:
Report can be used by individual purchaser only

Site License: 
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:  
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS


Companies

Bayer AG

Eli Lilly and Company

Neogen Corp

Zoetis Inc.